Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3Unknown 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 1Insulin Resistance 1Hyperandrogenism 1Hirsutism 1Dyslipidemias 1AML 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × OTHER × Magnesium × Clear all
NCT07298564 2025-12-23

Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)

Science & Research Islamic Azad University Branch Khozestan

Phase NA Recruiting
84 enrolled

Hirsutism, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Dyslipidemias

NCT06717958 2025-07-02

PIVOT

Technische Universität Dresden

Phase 2 Recruiting
76 enrolled

AML

Data powered by HemOnc (CC BY 4.0) Colophon âš¡